Inactive Instrument

STALLERGENES Stock

Equities

FR0000065674

Biotechnology & Medical Research

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

2014

DBV TECHNOLOGIES : French developer of 'peanut allergy patch' makes U.S. debut

RE

Latest news about STALLERGENES

DBV TECHNOLOGIES : French developer of 'peanut allergy patch' makes U.S. debut

14-10-22

RE

Press releases STALLERGENES

STALLERGENES : GREER ANNOUNCES ITS 2016 FINANCIAL CALENDAR	16-02-22	PU
STALLERGENES : MICHELE ANTONELLI APPOINTED PRESIDENT OF STALLERGENES SAS & EXECUTIVE VP HEAD OF EUROPE & ROW	16-02-10	PU
STALLERGENES : MICHELE ANTONELLI APPOINTED PRESIDENT OF STALLERGENES SAS AND EXECUTIVE VP, HEAD OF EUROPE & REST OF WORLD	16-02-10	PU
STALLERGENES : MICHELE ANTONELLI APPOINTED PRESIDENT OF STALLERGENES SAS AND EXECUTIVE VICE PRESIDENT, HEAD OF EUROPE & REST OF WORLD	16-02-10	PU
STALLERGENES : GREER ANNOUNCES RESUMPTION OF MANUFACTURING AT ITS ANTONY PLANT	16-02-01	PU

More press releases

News in other languages on STALLERGENES

Stallergenes Greer : des objectifs rassurants.	17-03-30
Les valeurs à suivre aujourd'hui à la Bourse de Paris - Jeudi 30 mars 2017	17-03-30
STALLERGENES : GREER a creusé sa perte nette en 2016	17-03-30
STALLERGENES : résultats positifs d'une étude	17-01-27
Les valeurs à suivre aujourd'hui à la Bourse de Paris - Jeudi 1er décembre 2016	16-12-01

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	+4.09%	43.43B
LONZA GROUP AG	+47.81%	41.69B
MODERNA, INC.	+9.45%	41.31B
CELLTRION, INC.	-10.92%	27.14B
ICON PUBLIC LIMITED COMPANY	+9.32%	25.28B
ALNYLAM PHARMACEUTICALS, INC.	-24.87%	18.47B
MEDPACE HOLDINGS, INC.	+29.70%	12.59B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.28%	12.33B
UNITED THERAPEUTICS CORPORATION	+7.78%	11.03B

Other Biotechnology & Medical Research

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer